Osaic Holdings’s Virax Biolabs VRAX Stock Holding History

Osaic Holdings’s Portfolio VRAX Stock Details VRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$4	–	8188
2026 Q1	$4	Hold	1	–	–	﹤0.01%	7766
2025 Q4	$7	Buy	+1	New	+$13	﹤0.01%	7771

Other funds holding VRAX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings's VRAX Position: Q2 2026 in Review

Osaic Holdings sold out of Virax Biolabs (VRAX) in Q2 2026, closing a stake of 1 share — an estimated $4 sold.

Osaic Holdings first reported a position in VRAX in Q4 2025 and held it in 2 quarters. The position peaked at $7 in Q4 2025. 2 funds tracked by Wall St. Rank hold VRAX as of Q2 2026.

Osaic Holdings reported no remaining Virax Biolabs position as of Q2 2026 after selling out during the quarter.
Osaic Holdings sold 1 Virax Biolabs share in Q2 2026, an estimated $4.
Osaic Holdings first reported a position in Virax Biolabs in Q4 2025 and held it in 2 quarters.
Osaic Holdings's Virax Biolabs position peaked at $7 in Q4 2025.
2 funds tracked by Wall St. Rank held Virax Biolabs as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.